Perimeter Medical Imaging AI

Perimeter Medical Imaging AI's mission is to transform cancer surgery by providing real-time, high-resolution visualization of surgical margins. The company has achieved a significant milestone with the FDA Premarket Approval (PMA) submission for its next-generation B-Series OCT with ImgAssist AI, following positive pivotal trial results demonstrating a statistically significant reduction in residual cancer. Its strategy focuses on commercializing its AI-enabled OCT platform initially in breast-conserving surgery, with a clear path to expand into other solid tumor indications.

Proprietary wide-field Optical Coherence Tomography (OCT) integrated with artificial intelligence (ImgAssist AI) for real-time, microscopic visualization and analysis of surgical tissue margins.

Perimeter competes with standard specimen radiography, Frozen Section Analysis, and point-detection devices like MarginProbe. Its key differentiator is the combination of real-time, depth-resolved (3D) imaging and an FDA-designated AI algorithm, offering a comprehensive visual map of the entire margin subsurface—a capability currently unmatched by other FDA-approved devices.